Common Contracts
2 similar Manufacturing Services Agreement contracts by Lucira Health, Inc.
MANUFACTURING SERVICES AGREEMENT between JABIL INC., and LUCIRA HEALTH INC.Manufacturing Services Agreement • January 15th, 2021 • Lucira Health, Inc. • In vitro & in vivo diagnostic substances • Delaware
This Manufacturing Service Agreement (“Agreement”) is entered into as of September 10th, 2020 (“Effective Date”) by and between Jabil Inc., having its principal place of business at 10560 Dr. M.L. King Jr. Street North St. Petersburg, Florida 33716, on behalf of itself and its affiliates (“Jabil”), and Lucira Health, Inc. a Delaware corporation, (“Company”). Jabil and Company are referred to herein individually as “Party”, or collectively as “Parties”.
MANUFACTURING SERVICES AGREEMENT between JABIL INC., and LUCIRA HEALTH INC.Manufacturing Services Agreement • November 23rd, 2020 • Lucira Health, Inc. • In vitro & in vivo diagnostic substances • Delaware
This Manufacturing Service Agreement (“Agreement”) is entered into as of September 10th, 2020 (“Effective Date”) by and between Jabil Inc., having its principal place of business at 10560 Dr. M.L. King Jr. Street North St. Petersburg, Florida 33716, on behalf of itself and its affiliates (“Jabil”), and Lucira Health, Inc. a Delaware corporation, (“Company”). Jabil and Company are referred to herein individually as “Party”, or collectively as “Parties”.
